Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

HIV-1 Drug Resistance Profiles for the HIV Protease and Reverse Transcriptase Gene in Patients Receiving Combination Therapy in Tehran, Iran.

Sadeghi L, Lolaie M, Tabatabai RA, Bayanolhagh S, Taj L, Ahmadi NE, Abedinzadeh N, Vakili F, Ahmadi G, Mohraz M.

Infect Disord Drug Targets. 2018;18(3):241-248. doi: 10.2174/1871526518666180416110259.

PMID:
29663899
2.

Different Degrees of Immune Recovery Using Antiretroviral Regimens with Vonavir or Zidovudine/Lamivudine/Efavirenz in HIVPositive Patients Receiving First Line Treatment in Iran.

Sadeghi L, Moallemi S, Tabatabai RA, Esmaeilzadeh A, Ahsani-Nasab S, Ahmadi NE, Bayanolhagh S, Lolaie M, Narouei A, SeyedAlinaghi S, Mohraz M.

Infect Disord Drug Targets. 2018;18(3):207-213. doi: 10.2174/1871526518666180108104031.

PMID:
29308748

Supplemental Content

Loading ...
Support Center